EU says cereulide exposure risk low after baby formula recalls

European authorities say the likelihood of infant exposure to the cereulide toxin is now low after precautionary recalls of formula linked to contaminated ingredients; several countries reported infants with mild gastrointestinal symptoms and a small number of hospitalisations.

European food and disease authorities have assessed that the chance of infants being exposed to the cereulide toxin is now low following precautionary recalls of infant formula. The recalls began in December and were expanded in February after the European Food Safety Authority advised a maximum threshold for cereulide in infant formula. Cereulide was detected in ingredients supplied from China that were used by several formula makers, prompting recalls in multiple countries. Authorities and investigators continue to monitor reports and examine possible links to severe outcomes. Key facts: - The European Food Safety Authority (EFSA) and the European Centre for Disease Prevention and Control (ECDC) said large-scale control measures have reduced the likelihood of exposure and that risk is considered low. - Cereulide is a toxin that can cause nausea and vomiting and was detected in ingredients from a supplier in China used by several formula makers, including some large companies reported in the coverage. - Recalls were initiated in December and broadened in February after EFSA advised on a maximum threshold for cereulide in infant formula. - As of Feb. 13, seven European countries (Austria, Belgium, Denmark, France, Luxembourg, Spain and the United Kingdom) had reported infants with gastrointestinal symptoms after consuming the affected formula. - Most reported cases involved mild symptoms; some infants were hospitalised for dehydration, and French investigators are examining the deaths of three babies who consumed recalled formula, with no causal link scientifically established. - Experts noted that symptoms resemble common viral stomach infections and that testing for cereulide is not widely available, which can complicate case identification. Summary: Authorities say the large-scale recalls and control measures have lowered the likelihood of infant exposure to cereulide, and most reported cases have been mild with a small number of hospitalisations. Investigations and monitoring are ongoing, including enquiries in France into three infant deaths; further findings and official updates are expected as those inquiries proceed.